Ravi Salgia
Affiliations: | Cancer Biology | University of Chicago, Chicago, IL |
Area:
Oncology, Molecular BiologyGoogle:
"Ravi Salgia"Collaborators
Sign in to add collaboratorShahid S. Siddiqui | collaborator | 2007- | Division of Biological Sciences, Pritzker School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ramisetty SK, Garg P, Mohanty A, et al. (2023) Regression of ovarian cancer xenografts by depleting or inhibiting RLIP. Biochemical Pharmacology. 217: 115847 |
Ebadi M, Ladbury C, Liu J, et al. (2023) Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung Cancer. Clinical Lung Cancer |
Liu J, Amini A, Govindarajan A, et al. (2023) Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the Block. Jco Precision Oncology. 7: e2200445 |
Shah A, Chaudhary S, Lakshmanan I, et al. (2023) Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies. Npj Precision Oncology. 7: 74 |
Guo L, Mohanty A, Singhal S, et al. (2023) Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors. Iscience. 26: 107302 |
Sattler M, Salgia R. (2023) LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer. Translational Lung Cancer Research. 12: 1350-1354 |
Garcia D, Mambetsariev I, Fricke J, et al. (2023) Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma. Cold Spring Harbor Molecular Case Studies. 9 |
Kostecki KL, Iida M, Wiley AL, et al. (2023) Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer. Head & Neck |
Sattler M, Mambetsariev I, Fricke J, et al. (2023) A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine. Journal of Clinical Medicine. 12 |
Zarinshenas R, Amini A, Mambetsariev I, et al. (2023) Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer. Cancers. 15 |